Psychosis in Patients With Parkinson Disease Without Dementia

How common is psychosis in PD? Implications? Risk factors? Insights here, and measures that may help.

Related Videos
Related Content

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023
© 2023 MJH Life Sciences

All rights reserved.